Chemcrux Enterprises Limited (BOM:540395)

India flag India · Delayed Price · Currency is INR
92.04
-1.22 (-1.31%)
At close: May 26, 2026
Market Cap1.36B -29.9%
Revenue (ttm)806.46M +14.1%
Net Income37.31M -4.7%
EPS2.52 -4.5%
Shares Out 14.81M
PE Ratio36.53
Forward PEn/a
Dividend1.00 (1.09%)
Ex-Dividend DateSep 17, 2025
Volume5,411
Open93.40
Previous Close93.26
Day's Range90.10 - 93.40
52-Week Range64.00 - 158.60
Beta0.34
Analystsn/a
Price Targetn/a
Earnings DateMay 14, 2026

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoy... [Read more]

Industry Chemicals and Allied Products
Founded 1983
Employees 102
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540395
Full Company Profile

Financial Performance

In fiscal year 2026, Chemcrux Enterprises's revenue was 806.46 million, an increase of 14.12% compared to the previous year's 706.67 million. Earnings were 37.31 million, a decrease of -4.66%.

Financial Statements